Aldeyra Therapeutics (ALDX)
1.78
+0.02 (1.14%)
Upcoming Events
Latest Headlines
Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Miller-Rich Nancy
June 11, 2026 4:27 PM - SEC Filing
Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: DOUGLAS RICHARD
June 11, 2026 4:26 PM - SEC Filing
Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Phillips Gary M.
June 11, 2026 4:26 PM - SEC Filing
Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Clark William D
June 11, 2026 4:24 PM - SEC Filing
Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Walker Neal
June 11, 2026 4:21 PM - SEC Filing
Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Bronstein Ben
June 11, 2026 4:21 PM - SEC Filing
Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: DEPTULA-HICKS DARLENE M
June 11, 2026 4:18 PM - SEC Filing
Form 3 Aldeyra Therapeutics, For: Jun 09 Filed by: DEPTULA-HICKS DARLENE M
June 11, 2026 4:13 PM - SEC Filing
Form 8-K Aldeyra Therapeutics, For: Jun 09
June 10, 2026 6:03 AM - SEC Filing
Aldeyra Therapeutics names Darlene Deptula-Hicks to board of directors
June 9, 2026 8:30 PM - StreetInsider
Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors
June 9, 2026 8:30 PM - BizWire
Form 4 Aldeyra Therapeutics, For: Jun 03 Filed by: Brady Todd C
June 5, 2026 4:19 PM - SEC Filing
Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
June 2, 2026 7:01 AM - BizWire
Form SCHEDULE 13G/A Aldeyra Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
May 15, 2026 4:00 PM - SEC Filing
Form 10-Q Aldeyra Therapeutics, For: Mar 31
May 7, 2026 4:03 PM - SEC Filing
Form 8-K Aldeyra Therapeutics, For: May 01
May 1, 2026 11:52 AM - SEC Filing
Form ARS Aldeyra Therapeutics, For: Dec 31
April 27, 2026 4:18 PM - SEC Filing
Form DEFA14A Aldeyra Therapeutics,
April 27, 2026 4:16 PM - SEC Filing
Form DEF 14A Aldeyra Therapeutics, For: Jun 10
April 27, 2026 4:10 PM - SEC Filing
Form 8-K Aldeyra Therapeutics, For: Apr 20
April 20, 2026 5:00 PM - SEC Filing
Form 8-K Aldeyra Therapeutics, For: Apr 01
April 1, 2026 4:26 PM - SEC Filing
Form 4 Aldeyra Therapeutics, For: Mar 27 Filed by: Brady Todd C
March 31, 2026 4:19 PM - SEC Filing
Form SCHEDULE 13G/A Aldeyra Therapeutics, Filed by: VANGUARD GROUP INC
March 26, 2026 3:26 PM - SEC Filing
Form 4 Aldeyra Therapeutics, For: Mar 19 Filed by: DOUGLAS RICHARD
March 20, 2026 4:18 PM - SEC Filing
Form 4 Aldeyra Therapeutics, For: Mar 18 Filed by: Alfieri Michael
March 19, 2026 5:29 PM - SEC Filing
Aldeyra Therapeutics ALERT: Securities Fraud Investigation by Block & Leviton Could Allow $ALDX Shareholders to Recover Losses
March 18, 2026 10:05 AM - StreetInsider
H.C. Wainwright Downgrades Aldeyra Therapeutics (ALDX) to Neutral
March 18, 2026 6:33 AM - StreetInsider
Increasing unusual put option volume: ALDX STWD JBL EWT FIVE KPTI BKLN
March 18, 2026 5:57 AM - StreetInsider
Full Article List
